0001493152-23-027815.txt : 20230811 0001493152-23-027815.hdr.sgml : 20230811 20230811160034 ACCESSION NUMBER: 0001493152-23-027815 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230101 FILED AS OF DATE: 20230811 DATE AS OF CHANGE: 20230811 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GIRGENTI STEVEN CENTRAL INDEX KEY: 0001055530 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41463 FILM NUMBER: 231163856 MAIL ADDRESS: STREET 1: C/O HEALTHWORLD CORP STREET 2: 100 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: bioAffinity Technologies, Inc. CENTRAL INDEX KEY: 0001712762 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 465211056 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 22211 WEST INTERSTATE-10 STREET 2: SUITE 1206 CITY: SAN ANTONIO STATE: TX ZIP: 78257 BUSINESS PHONE: 210-698-5334 MAIL ADDRESS: STREET 1: 22211 WEST INTERSTATE-10 STREET 2: SUITE 1206 CITY: SAN ANTONIO STATE: TX ZIP: 78257 4 1 ownership.xml X0508 4 2023-01-01 0 0001712762 bioAffinity Technologies, Inc. BIAF 0001055530 GIRGENTI STEVEN C/O BIOAFFINITY TECHNOLOGIES, INC. 22211 WEST INTERSTATE 10, SUITE 1206 SAN ANTONIO, TX 78257 1 1 0 0 Executive Chairman 0 Common Stock 2023-01-01 4 A 0 8227 2.28 A 869326 D Common Stock 2023-04-15 4 A 0 9920 1.89 A 879246 D Common Stock 2023-07-01 4 A 0 10245 1.83 A 889491 D Common Stock 2023-08-09 4 A 0 26315 2.28 A 915806 D Common Stock 8955 I By Trust Represents a grant from bioAffinity Technologies, Inc. (the "Issuer") to Mr. Girgenti of 8,227 restricted shares of common stock, par value $0.007 (the "Common Stock"), on January 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year. Represents a grant from the Issuer to Mr. Girgenti of 9,920 restricted shares of Common Stock on April 15, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest one-third on the date of grant, one-third on May 1, 2023 and the remaining shares on June 1, 2023, provided Mr. Girgenti continues to serve as a director, and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year. Represents a grant from the Issuer to Mr. Girgenti of 10,245 restricted shares of Common Stock, on July 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year. Represents a grant from the Issuer to Mr. Girgenti of 26,315 shares of Common Stock on August 9, 2023 pursuant to the terms of his employment agreement. Represents shares of Common Stock owned directly by the Cranye Girgenti Testamentary Trust (the "Trust") and indirectly by Mr. Girgenti, as co-trustee of the Trust, as previously reported on a Form 4 filed by Mr. Girgenti on November 8, 2022. Mr. Girgenti disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. Such total number of shares of Common Stock owned by the Trust, and by Mr. Girgenti indirectly. /s/ Steven Girgenti 2023-08-10